Products - Biliary tract cancers | Topic | NICE

Showing 1 product

Date | Title

Status: In consultationRemove ‘Status: In consultation’ filter

Zanidatamab for treating HER2-positive advanced biliary tract cancer after 1 or more lines of systemic treatment [ID6388]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
6 May 2026
Expected publication date:
7 May 2026